Skip to main content
Signal8

Stemtech Corp (STEK)

Sector: Wholesale-Drugs, Proprietaries & Druggists' Sundries

Industry: Drug Manufacturers - Specialty & Generic

Stemtech Corporation logo

Stemtech Corporation

OTC:STEKHealthcare
AH+0.00%$0.0001
Close$0.0001
Mkt Cap$300K
EV-
Float2.7B
O/S3B
VOL1.5M sh
$ Vol$150
RVOL0.13×
Inst Own-
Net Cash/Sh-
Dilution
Stemtech Corporation logoOTC:STEKAH$0.0001+0.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 17, 20260.00010.00010.00010.00011,500,012
Nov 16, 20260.00010.00010.00010.00011,576,286
Nov 13, 20260.00010.00010.00000.000036,963
Nov 12, 20260.00010.00010.00000.00001,877,470
Nov 11, 20260.00000.00010.00000.000027,000
Nov 10, 20260.00010.00020.00000.00011,520,280
Nov 9, 20260.00010.00010.00010.0001100,000
Nov 6, 20260.00010.00010.00010.00014,701,630
Nov 5, 20260.00010.00010.00010.000126,165,017
Nov 4, 20260.00010.00010.00010.000181,455,493
Nov 3, 20260.00010.00010.00010.0001304,564
Nov 2, 20260.00010.00010.00010.00012,293,800
Oct 30, 20260.00000.00010.00000.0001164,705
Oct 29, 20260.00010.00010.00000.00011,313,047
Oct 28, 20260.00010.00010.00010.0001162,900
Oct 27, 20260.00010.00010.00010.00018,630,000
Oct 26, 20260.00010.00010.00010.00015,071,306
Oct 23, 20260.00010.00010.00010.0001111,927,321
Oct 22, 20260.00010.00010.00010.0001249,000
Oct 20, 20260.00010.00010.00010.00012,000,000
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
InsiderTypeShares
KAPLAN BENJAMIN NATHANIEL profile photoKAPLAN BENJAMIN NATHANIELSale1.00M
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(1)
0.0%
5%+ Owners
(0)
100.0%
Unattributed (incl. retail)ⓘ
Insider0.0%
Unattributed (incl. retail)100.0%
Top Shareholders
NameShares%
KAPLAN BENJAMIN NATHANIEL profile photo
KAPLAN BENJAMIN NATHANIEL
Director
831.0K0.0%
Sources: Form 4O/S: 3.0B · as of 13 Nov 2026 · SEC filings
Insiders & Institutional Holders
About

Stemtech Corporation is a pioneering company specializing in stem cell nutrition.

It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality.

The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.

Key Metrics
Market Cap$299,703
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUSUS
IPO DateNov 26, 2021
Shares Outstanding3.00B
Authorized Shares
Float2.70B
Float (other source)2.75BSignal8 estimate from ownership filings · from 10-K, 2026-05-29
Float (bounds only)at most 2.76B
52-Week Range
$0.0000$0.0028
$0.0001(4th percentile)
Volume
Average Daily Volume11.97M
1.50M today vs 11.97M avg(-87%)

30d Avg

11.97M

60d Avg

8.49M

90d Avg

7.53M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Signal8's dilution snapshot of STEK as of Sep 30, 2026 records 1 outstanding warrant series, from SEC filings. Stemtech Corp (OTC: STEK) traded at $0.0001 on Nov 17, 2026. 52-week range: $0.0000 to $0.0028. The company is in the Healthcare sector (Drug Manufacturers - Specialty & Generic).